Pricing
Login
Home
Charts
Search
Watchlist
Products

Aurobindo Pharma Ltd

AUROPHARMA
₹1,799.00-0.37%20 Nov 2026
Reports
Pharma Formulations

Aurobindo Pharma Ltd

AUROPHARMA
₹1,799.00
-0.37%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,03,510Cr
Close
Close Price
₹1,799.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
26.09
PS
Price To Sales
2.80
Revenue
Revenue
₹36,913Cr
Rev Gr TTM
Revenue Growth TTM
13.53%
PAT Gr TTM
PAT Growth TTM
16.54%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
7,3527,5807,5677,7967,9798,3827,8688,2868,6468,8539,15010,263
Growth YoY
Revenue Growth YoY%
14.717.110.58.08.510.64.06.38.45.616.323.9
Expenses
ExpensesCr
5,7505,9075,9476,2306,4016,5906,2656,6086,8737,1017,2698,108
Operating Profit
Operating ProfitCr
1,6011,6731,6201,5661,5781,7921,6031,6781,7731,7531,8812,156
OPM
OPM%
21.822.121.420.119.821.420.420.320.519.820.621.0
Other Income
Other IncomeCr
1601220136159103107122123115223165
Interest Expense
Interest ExpenseCr
768911111311811598959398102102
Depreciation
DepreciationCr
423354404382419444406429465479487531
PBT
PBTCr
1,2621,2301,3241,2071,2001,3351,2071,2761,3391,2911,5151,688
Tax
TaxCr
322323406391354432383428429370483564
PAT
PATCr
9409079188178469038248489109211,0321,124
Growth YoY
PAT Growth YoY%
91.479.361.28.7-10.0-0.5-10.23.87.62.025.232.5
NPM
NPM%
12.812.012.110.510.610.810.510.210.510.411.310.9
EPS
EPS₹
16.015.515.714.014.615.614.214.615.715.917.919.6
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
7,3527,5807,5677,7967,9798,3827,8688,2868,6468,8539,15010,263
Growth YoY
Revenue Growth YoY%
14.717.110.58.08.510.64.06.38.45.616.323.9
Expenses
ExpensesCr
5,7505,9075,9476,2306,4016,5906,2656,6086,8737,1017,2698,108
Operating Profit
Operating ProfitCr
1,6011,6731,6201,5661,5781,7921,6031,6781,7731,7531,8812,156
OPM
OPM%
21.822.121.420.119.821.420.420.320.519.820.621.0
Other Income
Other IncomeCr
1601220136159103107122123115223165
Interest Expense
Interest ExpenseCr
768911111311811598959398102102
Depreciation
DepreciationCr
423354404382419444406429465479487531
PBT
PBTCr
1,2621,2301,3241,2071,2001,3351,2071,2761,3391,2911,5151,688
Tax
TaxCr
322323406391354432383428429370483564
PAT
PATCr
9409079188178469038248489109211,0321,124
Growth YoY
PAT Growth YoY%
91.479.361.28.7-10.0-0.5-10.23.87.62.025.232.5
NPM
NPM%
12.812.012.110.510.610.810.510.210.510.411.310.9
EPS
EPS₹
16.015.515.714.014.615.614.214.615.715.917.919.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
13,79514,91016,46319,56423,09924,77523,45524,85529,00231,72433,65336,913
Growth
Revenue Growth%
13.88.110.418.818.17.3-5.36.016.79.46.113.5
Expenses
ExpensesCr
10,60711,47512,69115,61218,23419,44119,06921,13723,15925,14126,80729,350
Operating Profit
Operating ProfitCr
3,1883,4343,7723,9524,8645,3334,3873,7195,8436,5836,8467,563
OPM
OPM%
23.123.022.920.221.121.518.715.020.120.820.320.5
Other Income
Other IncomeCr
205121105701513,140161279348590428625
Interest Expense
Interest ExpenseCr
25767782633057449140290457384395
Depreciation
DepreciationCr
3924285586689671,0551,1271,2451,5221,6491,7781,961
PBT
PBTCr
2,7443,0613,2413,0913,7437,3443,3732,6134,3805,0665,1125,832
Tax
TaxCr
7217608187278992,0107266851,2111,5831,6091,845
PAT
PATCr
2,0242,3012,4232,3652,8445,3342,6471,9283,1693,4843,5033,987
Growth
PAT Growth%
28.813.75.3-2.420.387.6-50.4-27.264.49.90.616.5
NPM
NPM%
14.715.414.712.112.321.511.37.810.911.010.410.8
EPS
EPS₹
34.739.341.440.448.391.045.232.954.259.860.369.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
13,79514,91016,46319,56423,09924,77523,45524,85529,00231,72433,65336,913
Growth
Revenue Growth%
13.88.110.418.818.17.3-5.36.016.79.46.113.5
Expenses
ExpensesCr
10,60711,47512,69115,61218,23419,44119,06921,13723,15925,14126,80729,350
Operating Profit
Operating ProfitCr
3,1883,4343,7723,9524,8645,3334,3873,7195,8436,5836,8467,563
OPM
OPM%
23.123.022.920.221.121.518.715.020.120.820.320.5
Other Income
Other IncomeCr
205121105701513,140161279348590428625
Interest Expense
Interest ExpenseCr
25767782633057449140290457384395
Depreciation
DepreciationCr
3924285586689671,0551,1271,2451,5221,6491,7781,961
PBT
PBTCr
2,7443,0613,2413,0913,7437,3443,3732,6134,3805,0665,1125,832
Tax
TaxCr
7217608187278992,0107266851,2111,5831,6091,845
PAT
PATCr
2,0242,3012,4232,3652,8445,3342,6471,9283,1693,4843,5033,987
Growth
PAT Growth%
28.813.75.3-2.420.387.6-50.4-27.264.49.90.616.5
NPM
NPM%
14.715.414.712.112.321.511.37.810.911.010.410.8
EPS
EPS₹
34.739.341.440.448.391.045.232.954.259.860.369.0
Sales CAGR
1 Year6%
3 Years11%
5 Years6%
TTM14%
EBITDA CAGR
1 Year4%
3 Years23%
5 Years5%
TTM14%
PAT CAGR
1 Year1%
3 Years22%
5 Years-8%
TTM17%
Avg. ROCE
1 Year12%
3 Years13%
5 Years12%
TTM13%
CFO / EBITDA
1 Year81%
3 Years62%
5 Years70%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
595959595959595959585858
Reserves
ReservesCr
7,2299,31311,62213,83216,76621,87124,51726,78129,78432,59537,83339,342
Current Liabilities
Current LiabilitiesCr
7,8406,6068,66612,02111,38510,6658,15611,49412,19914,68218,03919,667
Non Current Liabilities
Non Current LiabilitiesCr
7902707535417181,2601,1921,5443,0222,4562,5802,689
Total Liabilities
Total LiabilitiesCr
15,92016,24921,10126,45428,92833,85433,92239,89045,07249,78558,50261,754
Current Assets
Current AssetsCr
10,2949,20612,17815,33216,41319,82418,12321,46023,77227,16232,70933,959
Non Current Assets
Non Current AssetsCr
5,6267,0438,92311,12212,51514,03015,79918,43021,30022,62325,79327,796
Total Assets
Total AssetsCr
15,92016,24921,10126,45428,92833,85433,92239,89045,07249,78558,50261,754
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
595959595959595959585858
Reserves
ReservesCr
7,2299,31311,62213,83216,76621,87124,51726,78129,78432,59537,83339,342
Current Liabilities
Current LiabilitiesCr
7,8406,6068,66612,02111,38510,6658,15611,49412,19914,68218,03919,667
Non Current Liabilities
Non Current LiabilitiesCr
7902707535417181,2601,1921,5443,0222,4562,5802,689
Total Liabilities
Total LiabilitiesCr
15,92016,24921,10126,45428,92833,85433,92239,89045,07249,78558,50261,754
Current Assets
Current AssetsCr
10,2949,20612,17815,33216,41319,82418,12321,46023,77227,16232,70933,959
Non Current Assets
Non Current AssetsCr
5,6267,0438,92311,12212,51514,03015,79918,43021,30022,62325,79327,796
Total Assets
Total AssetsCr
15,92016,24921,10126,45428,92833,85433,92239,89045,07249,78558,50261,754

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,4203,2791,9551,6514,3813,3295,0162,3872,4353,9255,526
Investing Cash Flow
Investing Cash FlowCr
-1,445-1,787-1,927-2,903-1,568599-3,212-3,978-4,256-1,876-3,459
Financing Cash Flow
Financing Cash FlowCr
365-1,9158641,919-1,947-1,365-2,9691,814800120-1,269
Net Cash Flow
Net Cash FlowCr
340-4248926678662,563-1,164223-1,0212,169799
Free Cash Flow
Free Cash FlowCr
-1461,5949212473,0181,9393,345-6-2861,9602,887
CFO To PAT
CFO To PAT%
70.2142.580.769.8154.162.4189.5123.876.8112.7157.8
CFO To EBITDA
CFO To EBITDA%
44.595.551.841.890.162.4114.364.241.759.680.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,4203,2791,9551,6514,3813,3295,0162,3872,4353,9255,526
Investing Cash Flow
Investing Cash FlowCr
-1,445-1,787-1,927-2,903-1,568599-3,212-3,978-4,256-1,876-3,459
Financing Cash Flow
Financing Cash FlowCr
365-1,9158641,919-1,947-1,365-2,9691,814800120-1,269
Net Cash Flow
Net Cash FlowCr
340-4248926678662,563-1,164223-1,0212,169799
Free Cash Flow
Free Cash FlowCr
-1461,5949212473,0181,9393,345-6-2861,9602,887
CFO To PAT
CFO To PAT%
70.2142.580.769.8154.162.4189.5123.876.8112.7157.8
CFO To EBITDA
CFO To EBITDA%
44.595.551.841.890.162.4114.364.241.759.680.7

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
43,59539,55632,65046,05324,20251,65339,19630,35263,83567,35675,6901,03,510
Price To Earnings
Price To Earnings
21.517.413.519.58.59.714.815.720.119.321.626.1
Price To Sales
Price To Sales
3.22.62.02.41.12.11.71.22.22.12.32.8
Price To Book
Price To Book
6.04.22.83.31.42.41.61.12.12.12.02.6
EV To EBITDA
EV To EBITDA
14.812.39.512.95.69.78.68.011.010.210.813.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
48.049.651.647.751.153.249.647.049.851.652.252.2
OPM
OPM%
23.123.022.920.221.121.518.715.020.120.820.320.5
NPM
NPM%
14.715.414.712.112.321.511.37.810.911.010.410.8
ROCE
ROCE%
25.625.120.516.318.027.212.58.612.813.512.013.1
ROE
ROE%
27.824.620.717.016.924.310.87.210.610.79.210.1
ROA
ROA%
12.714.211.58.99.815.87.84.87.07.06.06.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
43,59539,55632,65046,05324,20251,65339,19630,35263,83567,35675,6901,03,510
Price To Earnings
Price To Earnings
21.517.413.519.58.59.714.815.720.119.321.626.1
Price To Sales
Price To Sales
3.22.62.02.41.12.11.71.22.22.12.32.8
Price To Book
Price To Book
6.04.22.83.31.42.41.61.12.12.12.02.6
EV To EBITDA
EV To EBITDA
14.812.39.512.95.69.78.68.011.010.210.813.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
48.049.651.647.751.153.249.647.049.851.652.252.2
OPM
OPM%
23.123.022.920.221.121.518.715.020.120.820.320.5
NPM
NPM%
14.715.414.712.112.321.511.37.810.911.010.410.8
ROCE
ROCE%
25.625.120.516.318.027.212.58.612.813.512.013.1
ROE
ROE%
27.824.620.717.016.924.310.87.210.610.79.210.1
ROA
ROA%
12.714.211.58.99.815.87.84.87.07.06.06.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,16,1191,14,3161,10,0771,03,51092,09974,73361,994
Close PriceClose₹1,390.201,415.002,665.001,799.002,014.002,648.005,185.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.3639.4549.0526.0917.2451.4929.98
Price To SalesPS3.514.067.162.803.004.693.97
RevenueRevenueCr33,09728,13915,37936,91330,74615,93715,632
Revenue Growth TTMRev Gr TTM%-3.5%-0.7%13.5%13.5%24.2%-0.1%12.5%
PAT Growth TTMPAT Gr TTM%-51.9%-47.4%27.6%16.5%20.1%43.7%-13.2%
Market CapitalizationMkt CapCr1,16,1191,14,3161,10,0771,03,51092,09974,73361,994
Close PriceClose₹1,390.201,415.002,665.001,799.002,014.002,648.005,185.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.3639.4549.0526.0917.2451.4929.98
Price To SalesPS3.514.067.162.803.004.693.97
RevenueRevenueCr33,09728,13915,37936,91330,74615,93715,632
Revenue Growth TTMRev Gr TTM%-3.5%-0.7%13.5%13.5%24.2%-0.1%12.5%
PAT Growth TTMPAT Gr TTM%-51.9%-47.4%27.6%16.5%20.1%43.7%-13.2%
Annual Reports
Quarterly Reports
FY
Annual Reports
Quarterly Reports
Interviews